Beam Therapeutics (NASDAQ:BEAM) said it plans to cut approximately 20% of its workforce, or around 100 jobs, as part of a corporate restructuring initiative. As a result of the layoffs, which are ...

(Reuters) -Beam Therapeutics said on Thursday it will focus on developing its experimental sickle cell disease treatments and reduce about 20% of its current workforce, or 100 employees, as part of a ...

As you might know, Beam Therapeutics Inc. (NASDAQ:BEAM) just kicked off its latest annual results with some very strong numbers. The results were impressive, with revenues of US$378m exceeding analyst ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. LIVERMORE — The first beams for the historic Norland’s barn reconstruction ...

— -- N E W Y O R K, May 28 — Hundreds of construction workers at Ground Zero watched tonight as the last steel beam left standing at the demolished World Trade Center was cut down, marking the ...

Beam Therapeutics set out to show how the precision of base-editing could produce new genetic medicines addressing a wide range of diseases. That goal may yet be realized, but the company is now ...

Two Columbus insurance startups have joined other young tech companies in the region that have been cutting jobs. Beam Dental, a tech startup best known for insuring people's teeth, and insurance ...

Beam Therapeutics was co-founded by David Liu, who invented base editing and prime editing technologies for gene editing. David Liu also co-founded Editas. The company is a recent IPO in preclinical ...